The LATAM Media Report
SEE OTHER BRANDS

Your media and advertising news from Latin America

The LATAM Media Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Media Report.

Press releases published on May 5, 2025

Ryman Hospitality Properties, Inc. Provides Updated Investor Presentation

Ryman Hospitality Properties, Inc. Provides Updated Investor Presentation

NASHVILLE, Tenn., May 05, 2025 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), a leading lodging and hospitality real estate investment trust that specializes in group-oriented, upscale convention center resorts and …

ASML reports transactions under its current share buyback program

ASML reports transactions under its current share buyback program

ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …

Greif, Inc. Announces 2025 Second Quarter Earnings Release and Conference Call Dates

Greif, Inc. Announces 2025 Second Quarter Earnings Release and Conference Call Dates

DELAWARE, Ohio, May 05, 2025 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today it will report the company’s 2025 second quarter financial results after the market closes on …

Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025

Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …

GraniteShares ETFs Announces Change to the Investment Objective on one of its Inverse Leveraged ETFs

GraniteShares ETFs Announces Change to the Investment Objective on one of its Inverse Leveraged ETFs

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- As announced on March 05, 2025 the investment strategy for the GraniteShares 1x Short COIN Daily ETF (ticker: CONI) will be amended and result in a new fund name and a new leverage factor. Effective May 05, 2025, …

Werewolf Therapeutics to Participate in Upcoming Investor Conferences

Werewolf Therapeutics to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …

Healthy Choice Wellness Corp. Completes Second Tranche of Debt-for-Equity Conversion

Healthy Choice Wellness Corp. Completes Second Tranche of Debt-for-Equity Conversion

HOLLYWOOD, FL, May 05, 2025 (GLOBE NEWSWIRE) -- Healthy Choice Wellness Corp. (NYSEAM: HCWC) today announced that it has further strengthened its balance sheet through the conversion of approximately $400,000 in outstanding debt into shares of the Company’ …

IMUNON to Hold First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 12, 2025

IMUNON to Hold First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 12, 2025

LAWRENCEVILLE, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, announces that the Company will host a conference call at 11:00 a.m. ET on Monday, …

MediWound to Report First Quarter 2025 Financial Results

MediWound to Report First Quarter 2025 Financial Results

YAVNE, Israel, May 05, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will report financial results for the first quarter ended March 31, 2025 on …

Immutep’s Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1

Immutep’s Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1

Complementary nature of these two immunotherapies leads to excellent 17.6-month median Overall Survival in head and neck cancer patients with PD-L1 CPS <1 Mature overall survival data builds on encouraging high response rates with multiple complete …

Sell Fast Chicagoland: Home Cash Buyers in Chicago Celebrate 20 Years of Delivering Swift Property Solutions

Sell Fast Chicagoland: Home Cash Buyers in Chicago Celebrate 20 Years of Delivering Swift Property Solutions

Glenview, IL, May 05, 2025 (GLOBE NEWSWIRE) -- Sell Fast Chicagoland, a leading cash home buyer specializing in fast, hassle-free home sales, is excited to announce the celebration of serving its local community with over 20 years of swift property …

Voreifarem Partners with SwfcNrho Exchange to Create a Global New Paradigm for Medical Data Valuation

Voreifarem Partners with SwfcNrho Exchange to Create a Global New Paradigm for Medical Data Valuation

New York, NY, May 05, 2025 (GLOBE NEWSWIRE) -- Recently, Voreifarem, the world’s first digital health project built on the core architecture of "medical chips + blockchain" (token abbreviation: IER), officially launched on the international mainstream …

Can-Fite Has Raised $175 Million in Total to Date for the Development of Namodenoson and Piclidenoson, Advancing into Pivotal Phase 3 Trials in Liver Cancer and Psoriasis

Can-Fite Has Raised $175 Million in Total to Date for the Development of Namodenoson and Piclidenoson, Advancing into Pivotal Phase 3 Trials in Liver Cancer and Psoriasis

Ramat Gan, Israel, May 05, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases, today announced that …

Valueex (VUEE) Exchange Opens IEO Window, Leading New Opportunities in Global Blockchain Investment

Valueex (VUEE) Exchange Opens IEO Window, Leading New Opportunities in Global Blockchain Investment

Fresno, CA, May 05, 2025 (GLOBE NEWSWIRE) -- In an era where blockchain technology and digital assets are rapidly rising, Initial Exchange Offerings (IEOs) have become an important avenue for investors to engage with emerging projects. Valueex Exchange ( …

PFMcrypto Launches the Best Free Digital Asset Management Platform in 2025, Attracting Millions Worldwide

PFMcrypto Launches the Best Free Digital Asset Management Platform in 2025, Attracting Millions Worldwide

New York, May 05, 2025 (GLOBE NEWSWIRE) -- In a year where passive income is more important than ever, PFMcrypto announces the expansion of its free digital asset management platform, now recognized as the most trusted way to earn passive income without …

American Tungsten Corp. Announces Changes to Board of Directors

American Tungsten Corp. Announces Changes to Board of Directors

Vancouver, BC, May 05, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) announces today the appointment of Dan Nicholas to the Board of Directors of the Company (the “Board”), and …

Palvella Therapeutics to Ring the Nasdaq Opening Bell on May 12, 2025

Palvella Therapeutics to Ring the Nasdaq Opening Bell on May 12, 2025

WAYNE, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from …

SEED Therapeutics Highlights Breakthrough Advances in Targeted Protein Degradation at AACR 2025

SEED Therapeutics Highlights Breakthrough Advances in Targeted Protein Degradation at AACR 2025

Novel RBM39 molecular glue achieves complete tumor regression in mechanism-based Ewing sarcoma models; IND filing expected mid-2025 Dual PROTAC strategy overcomes hook effect and enhances KRAS G12D degradation in collaboration with University of …

Creative Realities, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Information

Creative Realities, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Information

LOUISVILLE, Ky., May 05, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX), a leading provider of digital signage and media solutions, announced today that it will release its financial results …

SunHydrogen Contracts The Process Group for Front-End Engineering Design of 25m2 Renewable Hydrogen Pilot Plant

SunHydrogen Contracts The Process Group for Front-End Engineering Design of 25m2 Renewable Hydrogen Pilot Plant

Coralville, IA, May 05, 2025 (GLOBE NEWSWIRE) -- SunHydrogen, Inc. (OTC: HYSR), the developer of innovative technologies for producing renewable hydrogen using sunlight and water, today announced that it has contracted The Process Group, LLC (TPG Engineers …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service